Belgian Pharmaceuticals & Biotech Most Searched for companies on Simply Wall St (do not delete)

argenx

Market Cap: €44.6b

A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.

UCB

Market Cap: €44.9b

A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.

Financière de Tubize

Market Cap: €9.3b

Operates as a mono holding company whose sole investment is a stake in UCB which is a biopharma company in Belgium.

BioSenic

Market Cap: €1.6m

A biotechnology company, develops cell therapy products and treatments for autoimmune and inflammatory diseases in Belgium and France.

Oxurion

Market Cap: €475.7k

A biopharmaceutical company, develops medicines to prevent blindness in Belgium.

Hyloris Pharmaceuticals

Market Cap: €167.4m

Engages in the research, development, and manufacture of pharmaceutical products to address medical needs.

European Medical Solutions

Market Cap: €22.9m

Engages in the design, development, and manufacturing of medical imaging systems for digital radiology and bone densitometry in Belgium and internationally.

Celyad Oncology

Market Cap: €8.2m

A biotechnology company, focuses on the research and development of chimeric antigen receptor T cell (CAR T) therapies for cancer.